Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 4.3% – Here’s What Happened

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) fell 4.3% during mid-day trading on Friday . The stock traded as low as $21.16 and last traded at $21.1663. 30,940 shares changed hands during mid-day trading, a decline of 88% from the average session volume of 258,600 shares. The stock had previously closed at $22.11.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Trading Down 1.6%

The company has a market cap of $40.20 billion and a PE ratio of 20.02. The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06. The business has a 50 day simple moving average of $23.83 and a two-hundred day simple moving average of $24.04.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.